Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-02-24 @ 3:32 PM
Study NCT ID:
NCT03781869
Status:
UNKNOWN
Last Update Posted:
2018-12-20
First Post:
2018-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer
Sponsor:
Third Military Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ALT-SCLC-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None